Overview Dividends

(CLMT) Calumet Specialty Products - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1314761032

Specialty Lubricants, Base Oils, Solvents, Asphalt, Wax

CLMT EPS (Earnings per Share)

EPS Growth (3Y CAGR): 24.02%
EPS Trend (3Y Correlation): -39.8%

CLMT Revenue

Revenue Growth (3Y CAGR): -4.49%
Revenue Trend (3Y Correlation): -31.2%

Description: CLMT Calumet Specialty Products

Calumet Specialty Products Partners (NASDAQ:CLMT) is a US-based company operating in the Oil & Gas Refining & Marketing sub-industry. The companys quarterly tax provision is a crucial aspect of its financials, influencing its overall profitability.

To evaluate CLMTs performance, key performance indicators (KPIs) such as revenue growth, EBITDA margins, and debt-to-equity ratio are essential. The companys ability to manage its tax provision effectively can significantly impact its bottom line. A thorough analysis of CLMTs tax provision would involve examining its historical tax rates, deferred tax assets, and liabilities to understand potential future implications.

Key economic drivers for CLMT include crude oil prices, refining margins, and demand for petroleum products. Fluctuations in these drivers can significantly impact the companys revenue and profitability. Additionally, regulatory changes, such as those related to environmental policies, can also affect CLMTs operations and financials.

From a valuation perspective, CLMTs market capitalization and forward P/E ratio suggest that the market is pricing in expectations for the companys future performance. A detailed analysis of CLMTs financial statements, including its income statement, balance sheet, and cash flow statement, would provide further insights into its financial health and potential for future growth.

CLMT Stock Overview

Market Cap in USD	1,613m
Sub-Industry	Oil & Gas Refining & Marketing
IPO / Inception	2006-01-26

CLMT Stock Ratings

Growth Rating	1.54%
Fundamental	18.8%
Dividend Rating	11.7%
Return 12m vs S&P 500	-24.1%
Analyst Rating	3.86 of 5

CLMT Dividends

Currently no dividends paid

CLMT Growth Ratios

Growth Correlation 3m	73.2%
Growth Correlation 12m	-37.6%
Growth Correlation 5y	62%
CAGR 5y	3.52%
CAGR/Max DD 3y (Calmar Ratio)	0.06
CAGR/Mean DD 3y (Pain Ratio)	0.16
Sharpe Ratio 12m	-0.06
Alpha	-24.01
Beta	0.976
Volatility	38.60%
Current Volume	349.6k
Average Volume 20d	645.4k
Stop Loss	17.7 (-4.9%)
Signal	0.67

Piotroski VR‑10 (Strict, 0-10) 0.0

Net Income (-451.2m TTM) > 0 and > 6% of Revenue (6% = 244.2m TTM)

FCFTA -0.07 (>2.0%) and ΔFCFTA -3.89pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -6.88% (prev -9.95%; Δ 3.07pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA -0.05 (>3.0%) and CFO -126.9m > Net Income -451.2m (YES >=105%, WARN >=100%)

NO Net Debt/EBITDA fails (EBITDA <= 0)

Current Ratio 0.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (86.8m) change vs 12m ago 7.75% (target <= -2.0% for YES)

Gross Margin -0.90% (prev -10.83%; Δ 9.93pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 149.4% (prev 159.7%; Δ -10.27pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -0.54 (EBITDA TTM -93.3m / Interest Expense TTM 230.5m) >= 6 (WARN >= 3)

Altman Z'' -3.69

(A) -0.10 = (Total Current Assets 895.8m - Total Current Liabilities 1.18b) / Total Assets 2.78b

(B) -0.67 = Retained Earnings (Balance) -1.85b / Total Assets 2.78b

(D) -0.52 = Book Value of Equity -1.85b / Total Liabilities 3.54b

Total Rating: -3.69 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 18.83

1. Piotroski 0.0pt = -5.0

2. FCF Yield -11.52% = -5.0

3. FCF Margin -4.91% = -1.84

4. Debt/Equity -0.23 = -2.50

5. Debt/Ebitda -24.51 = -2.50

6. ROIC - WACC (= -20.27)% = -12.50

7. RoE 55.43% = 2.50

8. Rev. Trend -31.18% = -2.34

9. EPS Trend -39.77% = -1.99

What is the price of CLMT shares?

As of October 15, 2025, the stock is trading at USD 18.62 with a total of 349,588 shares traded.
Over the past week, the price has changed by +1.92%, over one month by +6.34%, over three months by +13.68% and over the past year by -12.91%.

Is Calumet Specialty Products a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Calumet Specialty Products (NASDAQ:CLMT) is currently (October 2025) a stock to sell. It has a ValueRay Fundamental Rating of 18.83 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CLMT is around 16.42 USD . This means that CLMT is currently overvalued and has a potential downside of -11.82%.

Is CLMT a buy, sell or hold?

Calumet Specialty Products has received a consensus analysts rating of 3.86. Therefore, it is recommended to buy CLMT.

Strong Buy: 2
Buy: 2
Hold: 3
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the CLMT price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	19.1	2.3%
Analysts Target Price	19.1	2.3%
ValueRay Target Price	18.8	0.8%

Last update: 2025-10-06 02:03

CLMT Fundamental Data Overview

Market Cap USD = 1.61b (1.61b USD * 1.0 USD.USD)
P/E Forward = 11.3507
P/S = 0.3962
P/B = 19.3228
P/EG = 2.71
Beta = 0.976
Revenue TTM = 4.07b USD
EBIT TTM = -125.2m USD
EBITDA TTM = -93.3m USD
Long Term Debt = 2.11b USD (from longTermDebt, last quarter)
Short Term Debt = 292.1m USD (from shortTermDebt, last quarter)
Debt = 231.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.29b USD (from netDebt column, last quarter)
Enterprise Value = 1.73b USD (1.61b + Debt 231.8m - CCE 110.6m)
Interest Coverage Ratio = -0.54 (Ebit TTM -125.2m / Interest Expense TTM 230.5m)
FCF Yield = -11.52% (FCF TTM -199.8m / Enterprise Value 1.73b)
FCF Margin = -4.91% (FCF TTM -199.8m / Revenue TTM 4.07b)
Net Margin = -11.08% (Net Income TTM -451.2m / Revenue TTM 4.07b)
Gross Margin = -0.90% ((Revenue TTM 4.07b - Cost of Revenue TTM 4.11b) / Revenue TTM)
Gross Margin QoQ = -4.25% (prev -8.19%)
Tobins Q-Ratio = 0.62 (Enterprise Value 1.73b / Total Assets 2.78b)
Interest Expense / Debt = 22.82% (Interest Expense 52.9m / Debt 231.8m)
Taxrate = -0.14% (negative due to tax credits) (200.0k / -147.7m)
NOPAT = -125.4m (EBIT -125.2m * (1 - -0.14%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 0.76 (Total Current Assets 895.8m / Total Current Liabilities 1.18b)
Debt / Equity = -0.23 (negative equity) (Debt 231.8m / totalStockholderEquity, last quarter -1.01b)
Debt / EBITDA = -24.51 (negative EBITDA) (Net Debt 2.29b / EBITDA -93.3m)
Debt / FCF = -11.45 (negative FCF - burning cash) (Net Debt 2.29b / FCF TTM -199.8m)
Total Stockholder Equity = -814.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -16.25% (Net Income -451.2m / Total Assets 2.78b)
RoE = 55.43% (negative equity) (Net Income TTM -451.2m / Total Stockholder Equity -814.0m)
RoCE = -9.69% (EBIT -125.2m / Capital Employed (Equity -814.0m + L.T.Debt 2.11b))
RoIC = -9.00% (negative operating profit) (NOPAT -125.4m / Invested Capital 1.39b)
WACC = 11.27% (E(1.61b)/V(1.84b) * Re(9.61%) + D(231.8m)/V(1.84b) * Rd(22.82%) * (1-Tc(-0.00)))
Discount Rate = 9.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.05%
Fair Price DCF = unknown (Cash Flow -199.8m)
EPS Correlation: -39.77 | EPS CAGR: 24.02% | SUE: 0.42 | # QB: 0
Revenue Correlation: -31.18 | Revenue CAGR: -4.49% | SUE: 1.45 | # QB: 2

Additional Sources for CLMT Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle